Nitto Avecia Facility World’s Largest of its Kind
Leading biopharmaceutical company Nitto Avecia engaged A/Z Corporation for the expansion of its Milford, MA facility. Nitto Avecia’s services support the pharmaceutical, biopharmaceutical and medical device industries. The expansion involved the addition of biologics manufacturing capacity, making it the largest cGMP oligonucleotide production facility in the world.
The $35 million project took place in two phases. Adhering to stringent cGMP requirements, the expansion adds significant cGMP manufacturing space, laboratories, office and storage to support the increased capacity of Nitto Avecia’s production capabilities.
The biopharma sector expertise brought by A/Z’s engineering and construction professionals has been instrumental in ensuring that this project met its completion date successfully as Nitto Avecia continues its strategic growth as a world-recognized leader in therapeutic nucleic acid manufacturing.